These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 28179196

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
    Shimizu T, Abu Lila AS, Fujita R, Awata M, Kawanishi M, Hashimoto Y, Okuhira K, Ishima Y, Ishida T.
    Eur J Pharm Biopharm; 2018 Jun; 127():142-149. PubMed ID: 29462689
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells.
    Shimizu T, Mima Y, Hashimoto Y, Ukawa M, Ando H, Kiwada H, Ishida T.
    Immunobiology; 2015 Oct; 220(10):1151-60. PubMed ID: 26095176
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.
    Wang X, Ishida T, Kiwada H.
    J Control Release; 2007 Jun 04; 119(2):236-44. PubMed ID: 17399838
    [Abstract] [Full Text] [Related]

  • 8. B cell-intrinsic toll-like receptor 7 is responsible for the enhanced anti-PEG IgM production following injection of siRNA-containing PEGylated lipoplex in mice.
    Hashimoto Y, Abu Lila AS, Shimizu T, Ishida T, Kiwada H.
    J Control Release; 2014 Jun 28; 184():1-8. PubMed ID: 24727075
    [Abstract] [Full Text] [Related]

  • 9. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
    Mima Y, Hashimoto Y, Shimizu T, Kiwada H, Ishida T.
    Mol Pharm; 2015 Jul 06; 12(7):2429-35. PubMed ID: 26070445
    [Abstract] [Full Text] [Related]

  • 10. A Maleimide-Terminally Modified PEGylated Liposome Induced the Accelerated Blood Clearance Independent of the Production of Anti-PEG IgM Antibodies.
    Ishima Y, Yamazaki N, Chuang VTG, Shimizu T, Ando H, Ishida T.
    Biol Pharm Bull; 2022 Jul 06; 45(10):1518-1524. PubMed ID: 36184510
    [Abstract] [Full Text] [Related]

  • 11. Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.
    Kozma GT, Mészáros T, Vashegyi I, Fülöp T, Örfi E, Dézsi L, Rosivall L, Bavli Y, Urbanics R, Mollnes TE, Barenholz Y, Szebeni J.
    ACS Nano; 2019 Aug 27; 13(8):9315-9324. PubMed ID: 31348638
    [Abstract] [Full Text] [Related]

  • 12. Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon.
    El Sayed MM, Takata H, Shimizu T, Kawaguchi Y, Abu Lila AS, Elsadek NE, Alaaeldin E, Ishima Y, Ando H, Kamal A, Sarhan HA, Ishida T.
    J Control Release; 2020 Jul 10; 323():102-109. PubMed ID: 32278827
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.
    Abu Lila AS, Kiwada H, Ishida T.
    J Control Release; 2013 Nov 28; 172(1):38-47. PubMed ID: 23933235
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Incorporating Gangliosides into PEGylated Cationic Liposomes that Complexed DNA Attenuates Anti-PEG Antibody Production but Not Anti-DNA Antibody Production in Mice.
    Qelliny MR, Shimizu T, Elsadek NE, Emam SE, Takata H, Fathalla ZMA, Hussein AK, Khaled KA, Ando H, Ishima Y, Ishida T.
    Mol Pharm; 2021 Jun 07; 18(6):2406-2415. PubMed ID: 33896187
    [Abstract] [Full Text] [Related]

  • 18. Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice.
    Hashimoto Y, Shimizu T, Abu Lila AS, Ishida T, Kiwada H.
    Biol Pharm Bull; 2015 Jun 07; 38(3):417-24. PubMed ID: 25757923
    [Abstract] [Full Text] [Related]

  • 19. Intravenous administration of polyethylene glycol-coated (PEGylated) proteins and PEGylated adenovirus elicits an anti-PEG immunoglobulin M response.
    Shimizu T, Ichihara M, Yoshioka Y, Ishida T, Nakagawa S, Kiwada H.
    Biol Pharm Bull; 2012 Jun 07; 35(8):1336-42. PubMed ID: 22863934
    [Abstract] [Full Text] [Related]

  • 20. T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes.
    Koide H, Asai T, Hatanaka K, Akai S, Ishii T, Kenjo E, Ishida T, Kiwada H, Tsukada H, Oku N.
    Int J Pharm; 2010 Jun 15; 392(1-2):218-23. PubMed ID: 20227473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.